InvestorsHub Logo
icon url

nuke661

09/30/12 4:26 PM

#96782 RE: cjgaddy #96780

CJ,

Thank you too for the great info you provided today. You continue to be an anchor point for great info.

Regarding the article's statement that CSM provided services for one of 3 double blind, placebo controlled studies of bavituximab; was that a misprint/mistake? I thought that the 2nd line NSCLC trial was the ONLY double blind, placebo controlled bavituximab trial ever done or currently being done. What am I missing? What are the other two double blind, placebo controlled trials? It would be great to have 2 other double, blind trials going on but I don't think they exist and I think the article was incorrect in this statement.
icon url

jimsgtx

09/30/12 4:33 PM

#96783 RE: cjgaddy #96780

CJ.. Love your post... One can only hope your right!
icon url

volgoat

09/30/12 4:44 PM

#96785 RE: cjgaddy #96780

Amen.

I would think Peregrine knows how many are still alive if they are still administering therapeutic doses.

Can't see the FDA rejecting a safe drug that extends life for this unmet need. First line MOS may also be compared to this trial to convince the FDA.